Education
About Us
Working with TipRanks
Follow Us
China Regenerative Medicine International Limited (HK:8158)
:8158
RESEARCH TOOLSreports
Total Valuation
China Regenerative Medicine International Limited has a market cap or net worth of HK$136.91M. The enterprise value is HK$485.59M.
Market CapHK$136.91M
Enterprise ValueHK$485.59M
Share Statistics
China Regenerative Medicine International Limited has 304,252,470 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding304,252,470
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China Regenerative Medicine International Limited’s return on equity (ROE) is 0.70 and return on invested capital (ROIC) is 7.21%.
Return on Equity (ROE)0.70
Return on Assets (ROA)0.13
Return on Invested Capital (ROIC)7.21%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee2.67M
Profits Per Employee522.12K
Employee Count34
Asset Turnover0.67
Inventory Turnover139.67
Valuation Ratios
The current PE Ratio of China Regenerative Medicine International Limited is 5.06. China Regenerative Medicine International Limited’s PEG ratio is >-0.01.
PE Ratio5.06
PS Ratio0.00
PB Ratio1.97
Price to Fair Value3.56
Price to FCF-6.29
Price to Operating Cash Flow-7.84
PEG Ratio>-0.01
Income Statement
In the last 12 months, China Regenerative Medicine International Limited had revenue of 90.62M and earned 17.75M in profits. Earnings per share was 0.06.
Revenue90.62M
Gross Profit57.65M
Operating Income18.88M
Pretax Income17.75M
Net Income17.75M
EBITDA29.84M
Earnings Per Share (EPS)0.06
Cash Flow
In the last 12 months, operating cash flow was -151.00K and capital expenditures 0.00, giving a free cash flow of -151.00K billion.
Operating Cash Flow-151.00K
Free Cash Flow-151.00K
Free Cash Flow per Share>-0.01
Dividends & Yields
China Regenerative Medicine International Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.37
52-Week Price Change181.25%
50-Day Moving Average0.37
200-Day Moving Average0.33
Relative Strength Index (RSI)64.68
Average Volume (3m)157.46K
Important Dates
China Regenerative Medicine International Limited upcoming earnings date is May 15, 2025, TBA Not Confirmed.
Last Earnings DateMar 28, 2025
Next Earnings DateMay 15, 2025
Ex-Dividend Date―
Financial Position
China Regenerative Medicine International Limited as a current ratio of 0.99, with Debt / Equity ratio of 336.10%
Current Ratio0.99
Quick Ratio0.99
Debt to Market Cap0.55
Net Debt to EBITDA4.62
Interest Coverage Ratio0.00
Taxes
In the past 12 months, China Regenerative Medicine International Limited has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
China Regenerative Medicine International Limited EV to EBITDA ratio is 18.01, with an EV/FCF ratio of 0.00.
EV to Sales1.33
EV to EBITDA18.01
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
China Regenerative Medicine International Limited has HK$57.45M in cash and marketable securities with HK$53.69M in debt, giving a net cash position of -HK$3.76M billion.
Cash & Marketable SecuritiesHK$57.45M
Total DebtHK$53.69M
Net Cash-HK$3.76M
Net Cash Per Share-HK$0.01
Tangible Book Value Per ShareHK$0.08
Margins
Gross margin is 60.28%, with operating margin of 6.77%, and net profit margin of 19.59%.
Gross Margin60.28%
Operating Margin6.77%
Pretax Margin19.59%
Net Profit Margin19.59%
EBITDA Margin7.40%
EBIT Margin6.77%
Analyst Forecast
The average price target for China Regenerative Medicine International Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―